Genopathy
Gene-Disorder Association · Article
Gene
APOE
Apolipoprotein E
Disorder
Dementia
Manually curatedApproved treatment annotated
Association Review

In brief

The association between APOE (Apolipoprotein E) and Dementia is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 12
Compounds 1
Trials 42of 271 via APOE compounds
Publications 60
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
APOE

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Dementia

The disorder

7 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Population genetics

GWAS signals

5 GWAS phenotypes

Gene-associated GWAS phenotypes matching the disorder, with best SNP, score, risk-allele frequency and effect size.

Request access
06
Interventions

Therapeutics

1 compound or drug

Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.

Request access
07
Human studies

Clinical trials

271 clinical trials

Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.

Request access
08
Literature

Reading

60 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
09
Provenance

References & sources

14 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access